Journal of Clinical Medicine Research, ISSN 1918-3003 print, 1918-3011 online, Open Access
Article copyright, the authors; Journal compilation copyright, J Clin Med Res and Elmer Press Inc
Journal website https://www.jocmr.org

Original Article

Volume 13, Number 8, August 2021, pages 420-424


Perinatal Transmission and Clinical Outcomes of Neonates Born to SARS-CoV-2-Positive Mothers

Table

Table 1. Clinical and Demographic Data of Neonates Born to SARS-CoV-2-Positive Mothers
 
CharacteristicsAll newborns (n = 130)SARS-CoV-2-positive (n = 16)SARS-CoV-2-negative (n = 112)P value
SARS-CoV-2: severe acute respiratory syndrome coronavirus 2; SD: standard deviation; ICU: intensive care unit.
Gestational age (weeks)36 (29 - 41)35 (3)37 (2.5)0.004
Gestational age < 34 weeks24 (18.46%)5 (31.25%)19 (17.0%)0.180
Birth weight (g) (mean ± SD)2,900 ± 6532,400 ± 7482,790 ± 6270.025
Cesarean section81 (66%)10 (62%)71 (62%)1.000
Male sex58 (45%)6 (37.5%)51 (45.53%)0.596
Apgar scores (mean)
  First minute878
  Fifth minute999
Neonatal ICU admission50 (38%)11 (68%)39 (34%)0.014
Bradycardia5 (3.85%)3 (18.8%)2 (1.8%)0.014
Respiratory support33 (25.38%)7 (43%)26 (22%)0.122
  Non-invasive295240.036
  Invasive4220.076
Surfactant therapy5 (3.85%)4 (25%)1 (0.9)0.001
Hyperbilirubinemia18 (13.85%)6 (37%)12 (10%)0.011
High C-reactive protein7 (5.4%)3 (18.8%)4 (3.6%)0.042
Received antibiotics in the first 48 h with negative cultures30 (23.1%)9 (56%)21 (18.8%)0.003
Breastfeeding60 (46.1%)8 (50%)52 (45%)0.796
Mortality3 (2.3%)1 (6%)2 (1.8%)0.332